Z-2150-2013 Class II Terminated
FDA device recall Z-2150-2013 was initiated by Genzyme Corporation, A Sanofi Company on June 21, 2013 and is designated Class II. Reason for recall: Product contains particulates (fibers) The recall status is terminated (terminated August 7, 2014). Affected quantity: 652 units.
Recall Details
- Product Type
- Devices
- Report Date
- September 11, 2013
- Initiation Date
- June 21, 2013
- Termination Date
- August 7, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 652 units
Product Description
LeGoo Internal Vessel Occluder 1mL Product Number: 10-0100 LeGoo is a water-soluble, biocompatible polymer with reverse thermo-sensitive properties allowing it to be injected as a soft viscoelastic gel that forms an elastic plug within the vessel. LeGoo is indicated for temporary endovascular occlusion of blood vessels up to 4 mm in diameter below the neck.
Reason for Recall
Product contains particulates (fibers)
Distribution Pattern
Worldwide Distribution - USA (nationwide) and internationally to Austria, Belgium, Canada, Denmark, Egypt. Europe, Finland, France, Germany, Hong Kong, Ireland, Italy, Netherlands, Poland, Saudi Arabia, Slovena, Spain, Sweden, Switzerland, The Netherlands, Turkey, and UK.
Code Information
All lot codes